The Official Publication Of The Florida Pharmacy Association FEB. 2020
WHAT YOU NEED TO KNOW ABOUT
COVID-19
GENERIC NET PRICING BUILT FOR YOUR BOTTOM LINE
What’s NEXT
for your pharmacy ?
Independent pharmacies’ preferred Generic Rx partner just got better. API’s warehouse program is designed to improve cash flow, and is an ideal solution for LTC pharmacies.
RX
OVER 2,000 GENERIC SKUs - everything you need to take care of your patients
MEMBER OWNED
20% INSTANT GENERIC REBATE - keep YOUR money in your pocket ADDITIONAL MONTHLY GENERIC REBATES - additional savings after the close of the month ANNUAL GENERIC LOYALTY REBATES - MORE money back on qualified annual purchases NEXT DAY DELIVERY - the generics you need, when you need them
GET STARTED TODAY
with API, AAP’s Member-Owned Warehouse
(800) 243-8521 | RxAAP.com/APIforLTC
florida PHARMACY TODAY Departments 4 Calendar 4 Advertisers 5 President's Viewpoint
7 Executive Insight
16 News & Notes
VOL. 83 | NO. 2 FEBRUARY 2020 THE OFFICIAL PUBLICATION OF THE FLORIDA PHARMACY ASSOCIATION
Features
10 12 15 17
What You Need to Know About COVID-19
Aclidinium Bromide/Formoterol Fumarate Inhalation Powder FPA Elects Regional Directors and Pharmacist Technician Board Member
New FPA President Elect
FEBRUARY 2020
|
3
Mission Statements:
FPA Calendar 2020
13
MARCH 13
Legislative Session Ends
20-23 APhA Annual Meeting National Harbor, Maryland APRIL 7-8
Florida Board of Pharmacy Meeting Gainesville, Florida
10
Good Friday, FPA Office Closed
18-19 Clinical Conference Grand Hyatt Tampa Bay
16 - 17 FPA CE Conference Jacksonville, Florida 17-19 NASPA Leadership Retreat San Antonio, Texas 25
Memorial Day, FPA Office Closed JUNE
2-3
Florida Board of Pharmacy Meeting Jacksonville, Florida JULY
21-22 NCPA Fly-in Washington, D.C.
9-12
MAY 8
House of Delegates Board of Directors conference call meeting
130th FPA Meeting and Convention Marco Island, Florida
Last day to submit resolutions to the House of Delegates
FOR A COMPLETE CALENDAR OF EVENTS GO TO WWW.FLORIDAPHARMACY.ORG
Events calendar subject to change
CE CREDITS (CE cycle) The Florida Board of Pharmacy requires 10 hours’ LIVE continuing education as part of the required 30 hours’ general education needed every license renewal period. There is a 2 hour CE requirement for pharmacists on the dispensing of controlled substances effective this biennial renewal period. Pharmacists and pharmacy technicians must also complete a 1 hour Florida Board approved continuing education on human trafficking by Jan. 1, 2021. Pharmacists should have satisfied all continuing education requirements for this biennial period by Sept. 30, 2021 or prior to licensure renewal. Consultant pharmacists and technicians will need to renew their licenses and registrations by Dec.31, 2020. For the Pharmacy Technician Certification Board application, exam information and study materials, please contact the FPA office. For more information on CE programs or events, please contact the Florida Pharmacy Association at (850) 222-2400 or visit our website at www.floridapharmacy.org CONTACTS FPA — Michael Jackson (850) 222-2400
FSHP — Tamekia Bennett (850) 906-9333 UF — Emely McKitrick (352) 273-5169
FAMU — Leola Cleveland (850) 599-3301 NSU — Carsten Evans (954) 262-1300
Note: The views of the authors do not necessarily represent the views or opinions of the Florida Pharmacy Association, Florida Pharmacy Today or any related entities.
Florida Pharmacy Today Journal The Florida Pharmacy Today Journal is a peer-reviewed journal which serves as a medium through which the Florida Pharmacy Association can communicate with the profession on advances in the sciences of pharmacy, socio-economic issues bearing on pharmacy and newsworthy items of interest to the profession. As a self-supported journal, it solicits and accepts advertising congruent with its expressed mission.
Florida Pharmacy Today Board of Directors The mission of the Florida Pharmacy Today Board of Directors is to serve in an advisory capacity to the managing editor and executive editor of the Florida Pharmacy Today Journal in the establishment and interpretation of the Journal’s policies and the management of the Journal’s fiscal responsibilities. The Board of Directors also serves to motivate the Florida Pharmacy Association members to secure appropriate advertising to assist the Journal in its goal of self-support.
Advertisers API.......................................................................... 2 BOWL OF HYGEIA............................................ 18 KAHAN & ASSOCIATES................................. 15 PQC...................................................................... 14 PARTNERSHIP FOR SAFE MEDICINES......... 9 PHARMACISTS MUTUAL.............................. 28
DISCLAIMER Articles in this publication are designed to provide accurate and authoritative information with respect to the subject matter covered. This information is provided with the understanding that neither Florida Pharmacy Today nor the Florida Pharmacy Association is engaged in rendering legal or other professional services through this publication. If expert assistance or legal advice is required, the services of a competent professional should be sought. The use of all medications or other pharmaceutical products should be used according to the recommendations of the manufacturers. Information provided by the maker of the product should always be consulted before use.
4 |
FLORIDA PHARMACY TODAY
EMAIL YOUR SUGGESTIONS/IDEAS TO dave@fiorecommunications.com
The President’s Viewpoint DAVID "CHACHI" MACKERAY, RPH
F
Games People Play
rom a young age we are taught to play games for reasons such as interacting with others, education, learning to achieve a common goal, learning how to strategize, and of course, becoming a unified team that works as one. As we get a little older, it really doesn’t change much; maybe the games become more organized and the rules multiply and become more specific. Later, only the talented and serious people participate, and the intensity increases. Now, we are adults and it’s at a whole new level. You may be now thinking that I’m referring to sports or another organized competitive activity. You are partially correct, but I’m also referring to our everyday life. Life itself can be considered a game. We all are trying to survive, be successful in our career, stay healthy and beat any negative conditions, and even win the hearts of those we love. I believe that we still actually continue to play games throughout our lives. Last month I traveled to Tallahassee for my annual participation in the FPA Legislative Days event and observed some things that I would like to share with you. First and foremost, I would like to thank each of you for your participation and involvement in this important and vital FPA event. Your presence at the Capitol means so much to the pharmacy profession. Your voices are heard by each legislator you spoke with. The white coats walking the halls and filling the seats in the committee meetings, the pharmacy students proudly voicing their opinion at the committee hearings, the informative press conference for Test and Treat that the public undoubtedly found educational and beneficial, and the awesome PBM Pep Rally with signs
and chants that energized everyone — all of these things are important to our efforts. So, as you can see, this is part of what we must do for our beloved pharmacy profession. We have to travel to places like Tallahassee and Washington, D.C., to fight for protecting and advancing pharmacy, because without our voices,
First and foremost, I would like to thank each of you for your participation and involvement in this important and vital FPA event. Your presence at the Capitol means so much to the pharmacy profession. our profession would either become non-existent or not have the same high standards or services we enjoy today. It’s unfortunate that we have to do this, but it’s part of the political game. We have no choice but to participate or others will decide and make choices for our profession. Those choices most
David Mackeray, RPh
likely will not be positive or beneficial for us or our patients. More importantly than the game itself, in my personal opinion, is how you play it. As I said earlier, we are taught at a very young age how to play games, but as adults, it’s so important to truly understand the impact of playing properly. First, we must always remember act and react professionally, even though we are so tempted to scream, yell and curse, we must not lower ourselves. Unfortunately, the rules aren’t clear or even explained properly, and they may not be fair to all participants. However, we must learn how to best play this game of politics if we ever want to be heard, taken seriously, make major advancements and achieve successful outcomes. Allow me to share with you an example of something that happened to me this year at the Florida Capitol. As the FPA president, I was introduced to and spoke with many highly respected and very influential senators and FEBRUARY 2020
|
5
2019-2020 FPA Board of Directors The Florida Pharmacy Association gratefully acknowledges the hard work and dedication of the following members of the FPA leadership who work diligently all year long on behalf of our members.
Angela Garcia.....................................................................................................Board Chair David Mackarey..........................................................................................FPA President Kimberly Jones.......................................................................................... FPA Treasurer Joseph Scuro............................................................................................ President Elect Gary Koesten..............................................................................Speaker of the House Eric Larson.......................................................................Vice Speaker of the House Bill Kernan................................................................................................... FSHP President Preston McDonald............................................................................. Region 1 Director Neil Barnett............................................................................................Region 2 Director Larry Alaimo..........................................................................................Region 3 Director Cheryl Rouse.........................................................................................Region 4 Director James Alcorn.......................................................................................Region 5 Director Barbara Beadle...................................................................................Region 6 Director Paul Delisser.......................................................................................... Region 7 Director Ramy Gabriel.........................................................................................Region 8 Director Mitchell Levinson...............................................................................Region 9 Director Julie Burger.......................................................................................Technician Director
Florida Pharmacy Today Journal Board Chair.............................................................. Carol Motycka, motycka@cop.ufl.edu Vice Chair....................................................Cristina Medina, cmmedina@cvs.com Treasurer.........................................................Eric Jakab, ericjakab@hotmail.com Secretary............................................. Julie Burger, julieburger133@gmail.com Member.................................................. Michael Finnick, michaelfinnick@ufl.edu Member.....................................................David Mackarey, dmackarey@aol.com Member.......................................................Matt Schneller, schnem18@gmail.com Member..........................................Teresa Tomerlin, teresapharmd@cfl.rr.com Member............................................Greta Pelegrin, gretapelegrin@yahoo.com Technician Member........................Julie Burger, julieburger133@gmail.com Executive Editor................Michael Jackson, mjackson@pharmview.com Managing Editor...................Dave Fiore, dave@fiorecommunications.com Journal Reviewer....................... Dr. Melissa Ruble, mruble@health.usf.edu Journal Reviewer....................................Dr. Angela Hill, ahill2@health.usf.edu
6 |
FLORIDA PHARMACY TODAY
representatives. One in particular shared with me his thoughts regarding our Pharmacy Legislative Days. He congratulated us for our large turnout, the amount of passion shown, and the opinions of all those who spoke from the heart. However, he did politely and respectfully share his concerns about the FPA not presenting our group in total agreement, which took him and others by surprise. He mentioned “success is best achieved when majority of members are in agreement and not so divided.” He also mentioned that “it’s not so much of importance having multiple supporters repeating the same points, but much more effective and successful having multiple valid points made supporting your stand.” Now, I’m not saying what we did was wrong or incorrect, but it’s the perception of others, including those representatives whose support and votes we need on so many bills. This one PBM Bill may have done some damage or discredit to our association. So, as the saying goes, “it’s not if you win or lose, but how you play the game.” We need to always keep this concept in mind as we move forward when fighting our causes. Perception has so much influence on the outcomes of what one is actually trying to achieve. Let’s not lessen or hurt our efforts of winning because we didn’t play properly or offended others along the way, even if it wasn’t our intent. We need to show unity and be very well prepared. Sometimes, in the game of life, it’s not always fair. We must be the bigger, stronger and more professional group that always acts with the highest ethics and values. n
Executive Insight BY MICHAEL JACKSON, RPH MICHAEL JACKSON, BPHARM, EVP & CEO, FLORIDA PHARMACY ASSOCIATION
U
Turning the Light on PBMs
nless you have been hiding under a rock or stranded on a deserted island in the Pacific Ocean for the past few decades, you probably are aware of what pharmacy benefit managers are doing to the profession of pharmacy. You can’t go to a meeting, pick up a health care publication or engage in a conversation with a colleague without this coming up as a topic of discussion. This issue is pinging very brightly on the FPA radar scope and has consumed our efforts during the legislative session. Let’s go back and review the origins of this industry. In the beginning, PBMs were mostly considered third-party claims processors whose function was primarily to conduct the transaction of prescription information between the pharmacy provider and the payer of pharmacy services. Fast forward to today, and you see a much more complex industry with a lot of secretive and proprietary business practices unknown to the pharmacy, the payer and the patient. For years, our members have complained about how PBMs operate. They have been unable to find a way to overcome the death grip that PBMs have in the pharmacy marketplace. We hear of continuous claims by the PBMs that they are the masterminds behind keeping costs under control, yet we continue to hear stories of outrageous prices related to life-sustai n i ng medications for health conditions related to cancer and diabetes. Over the years, we had to convince an unwilling Florida legislat ure to write laws to reign in PBM antipharmacy business behavior such as aggressive and unfair auditing practices, penalizing pharmacies that simply wish to share with patients
lower out-of-pocket cost options such as paying cash for their prescriptions rather than billing their insurance company, or getting PBMs to update their maximum allowable cost pricing
For years, our members have complained about how PBMs operate. They have been unable to find a way to overcome the death grip that PBMs have in the pharmacy marketplace. lists. With each new policy we convince the Florida House and Senate to accept, new onerous PBM problems rise to the surface. It’s the ultimate game of Whack-A-Mole. Also, every attempt to write public policy to get more transparency and accountability in the PBM marketplace means that data has to be provided to the legislature so that they can make informed decisions. Where is the solution going to come from? It just so happens that the Florida Pharmacy Association, along with American Pharmacy Cooperative Inc.,
Michael Jackson, B.Pharm
worked together to commission an exhaustive study of Florida Medicaid prescription drug claims. FPA member James Wright filed a public records request and got access to 350 million de-identified prescription drug claims from the Agency for Health Care Administration’s Medicaid program. This data was turned over to a company called 3 Axis Advisors who has been involved in researching similar state programs in Ohio, Kentucky, Georgia, New York, Illinois, Michigan, Virginia and Maryland. The intent was to examine this data to see if evidence of spread pricing found in other states could be happening here in Florida. Spread pricing could be defined as payments to pharmacy providers that may be different than what is billed to the payer. What did the analysis of the data discover? To the credit of Florida’s Agency for Health Care administration, evidence FEBRUARY 2020 |
7
FPA STAFF Executive Vice President/CEO Michael Jackson (850) 222-2400, ext. 200
Director of Continuing Education Tian Merren-Owens, ext. 120
Continuing Education Coordinator Stacey Brooks, ext. 210 Coordinator of Membership Christopher Heil, ext. 110
FLORIDA PHARMACY TODAY BOARD Chair............................... Carol Motycka, St. Augustine Vice Chair.........................Cristina Medina, Hollywood Treasurer.................................... Eric Jakab, Gainesville Secretary............................. Julie Burger, Pensacola Member.........................Michael Finnick, Jacksonville Member.............David Mackarey, Boynton Beach Member....................................... Matt Schneller, Tampa Member............................Teresa Tomerlin, Rockledge Member...................................... Greta Pelegrin, Hialeah Technician Member..........Julie Burger, Pensacola Executive Editor.......Michael Jackson, Tallahassee Managing Editor...................Dave Fiore, Tallahassee Journal Reviewer........................... Dr. Melissa Ruble Journal Reviewer....................................Dr. Angela Hill This is a peer-reviewed publication. ©2020 FLORIDA PHARMACY JOURNAL, INC. ARTICLE ACCEPTANCE: The Florida Pharmacy Today is a publication that welcomes articles that have a direct pertinence to the current practice of pharmacy. All articles are subject to review by the Publication Review Committee, editors and other outside referees. Submitted articles are received with the understanding that they are not being considered by another publication. All articles become the property of the Florida Pharmacy Today and may not be published without written permission from both the author and the Florida Pharmacy Today. The Florida Pharmacy Association assumes no responsibility for the statements and opinions made by the authors to the Florida Pharmacy Today. The Journal of the Florida Pharmacy Association does not accept for publication articles or letters concerning religion, politics or any other subject the editors/publishers deem unsuitable for the readership of this journal. In addition, The Journal does not accept advertising material from persons who are running for office in the association. The editors reserve the right to edit all materials submitted for publication. Letters and materials submitted for consideration for publication may be subject to review by the Editorial Review Board. FLORIDA PHARMACY TODAY, Annual subscription - United States and foreign, Individual $36; Institution $70/year; $5.00 single copies. Florida residents add 7% sales tax. FLORIDA PHARMACY ASSOCIATION
610 N. Adams St. • Tallahassee, FL 32301 850/222-2400 • FAX 850/561-6758 Web address: www.floridapharmacy.org
of spread pricing has largely been removed from Florida Medicaid with the exception of one health plan. There were, however, a number of troubling issues discovered in the analysis that we believe turns the light on what PBMs are doing in Florida and why pharmacy gross margins are so depressed in Florida Medicaid. Without going into any detail, which is another way of suggesting that you review the 3 Axis report yourself, below are examples of several key findings that the members need to be aware of. ■ Payments to pharmacies on the same NDC number of a drug varied widely within a PBM even when pharmacies were geographically located in the same area. ■ Pharmacies that were closely affiliated with PBMs appear to enjoy much better gross margins than pharmacies that were not affiliated. ■ Pharmacies appear to be much more compliant to the state’s preferred drug list for fee-forservice patients than patients covered under the managed care organizations. This means that the state may be missing out on rebate dollars that Florida would be entitled to. ■ Managed care organizations and PBMs often require that specialty drugs be dispensed at their affiliated pharmacies and the report is showing payments to these pharmacies far exceeding their cost to dispense What are the conclusions from this study? The Florida Medicaid program is mostly managed and driven by the managed care organizations that contract with middlemen called pharmacy benefit managers. While they are charged with controlling costs in the care of Florida Medicaid patients, they are doing so at the expense of non-affiliated pharmacies. That does not follow the principles of
a free market society. Essentially, you have a managed care organization that is handed tax money and instructed by the state to care for Florida’s indigent population. What we are gleaning from the report is that if you are an affiliated pharmacy to the PBM, you did well serving these patients. If you are an unaffiliated pharmacy — which many small pharmacy businesses are — you are literally bleeding gross margin. It is also very likely that these businesses are located in high Medicaid areas of Florida and not a lot of commercial plans or cash customers to make up for the losses. It just does not seem right in a true free market system that a competitor entity is given the ability to set and establish prices in a discriminating fashion the way it is being done here in Florida. Clearly, the legislature needs to act on this issue and make some policy changes to put the free back into free market. What can I do about this? Our members are now armed with a comprehensive report of the state’s own data showing clear evidence of a very broken pharmacy market in the Medicaid program. The association is working hard with a number of pharmacy stakeholders to convince the Florida House and Senate that a change is needed and that allowing t h is issue to fester is harming legitimate businesses in this state. You should have a conversation with your state legislator helping to inform them of what is happening. We have a special web site set up to guide you. Visit https://patientsaboveprofits.org for more information. n
What You Need to Know About COVID-19 Centers for Disease Control and Prevention How do you get it? While COVID-19 did originate in bats and possibly in a live animal market in Wuhan, most of the cases now were spread from human to human. It can spread between people who are in close contact with one another, via respiratory droplets from an infected person’s cough or sneeze. It may also be possible that a person can get COVID-19 by touching a surface or object that has the virus on it, then touching their own mouth, nose or eyes. How viruses spread around populations varies. In China, COVID-19 is spreading easily and sustainably in Hubei, Wuhan’s province. But in the U.S., there have been few human-to-human cases, and only among the close contacts of infected people.
COVID-19 is the official name for the coronavirus that’s affected thousands around the world. Here’s what you need to know about this contagious disease, courtesy of the Centers for Disease Control and Prevention. What is It? COVID-19 is a new type of coronavirus that has not been previously identified. It is similar to, but not the same, as coronaviruses that more commonly circulate around humans, like the common cold. A diagnosis with coronavirus 229E, NL63, OC43 or HKU1 is not the same as a diagnosis of coronavirus COVID-19. The name, chosen by the World Health Organization, comes from CO for corona, VI for virus and D for disease. It was discovered in 2019 in and around Wuhan, Hubei, China. The name was selected following the World Heath Organization’s best practices for naming new human infectious diseases. Coronaviruses are a large family of viruses that cause illnesses in people and animals. It includes Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Like those two diseases, COVID-19 originated in an animal population, in this case bats. So it can be spread two ways: animal-to-human and human-to-human. 10
|
FLORIDA PHARMACY TODAY
How can members of the general public protect themselves? There’s no vaccine for COVID-19 as of press time. But you can still protect yourself from this virus and the much more common flu bug by following these steps: ■ Avoid close contact with people who are sick. ■ Avoid touching your eyes, nose and mouth. ■ Stay home when you are sick. ■ Cover your cough or sneeze with a tissue, then throw the tissue in the trash. ■ Clean and disinfect frequently touched objects and surfaces using a regular household cleaning spray or wipe. ■ The CDC does not recommend using a face mask to protect yourself from respiratory viruses. Face masks should be used by people who are ill to help prevent the spread of disease to others. Face masks are also critical for health workers and people who are taking care of someone in a close setting, either at home or in the hospital. ■ Wash your hands often with soap and water for at least 20 seconds, especially after going to the bathroom, eating, blowing your nose, coughing or sneezing. If you don’t have access to soap and water, use an alcohol-based hand sanitizer with at least 60 percent alcohol. Always wash your hands if they are visibly dirty. What is the clinical presentation of COVID-19? Most of the reports that describe the clinical presentation of patients with confirmed COVID-19 infection come from hospitalized patients with pneumonia. The incubation period is estimated at around five days, but some studies have estimated a wider range and information gleaned from human infections with other coronaviruses, such as MERS and SARS, suggest the incubation period may range from two-14 days.
Frequently reported signs and symptoms of COVID-19 infection include: ■ Fever. ■ Cough. ■ Myalgia or fatigue. ■ Shortness of breath. ■ Sore throat. ■ Sputum production. ■ Headache. ■ Hemoptysis. ■ Diarrhea. Risk factors are not yet clear, but older patients and those with chronic illnesses may be at higher risk for severe illness. Most reported cases are in adults with a median age of 59 years. A little more than half were male. About a third to a half had underlying comorbidities, including diabetes, hypertension and cardiovascular disease. Critically ill patients were older and were more likely to have underlying comorbid conditions. Some reports suggest there may be a clinical deterioration in the patient’s second week of illness, with just over half of patients developing dyspnea a median eight days after illness onset with a range of five-13 days for the development. In another report, the mean time from illness onset to hospital admission with pneumonia was nine days. From 17-29 percent of hospitalized patients developed acute respiratory distress syndrome and about 10 percent developed a secondary infection. Between 23-32 percent of hospitalized patients required intensive care for respiratory support. Some patients have required advanced organ support with endotracheal intubation and mechanical ventilation, and a small proportion have also been supported with extracorporeal membrane oxygenation. Nosocomial transmission among health care personnel and patients has been reported. What are the testing protocols if COVID-19 is suspected? Testing for COVID-19 can only take place at the CDC as of press time. State and local health departments who have identified a person under investigation should notify the CDC’s Emergency Operations Center to report the person and determine whether testing for COVID-19 is necessary. The EOC will help local and state authorities collect, store and ship specimens to the CDC, including after hours or on weekends or holidays. A negative result means that the COVID-19 virus was not found in the person’s sample. However, in the early stages of infection, it is possible the virus will not be detected. For COVID-19, a negative test result means it is not likely that COVID-19 is causing their illness.
infected with COVID-19. In-vitro or in-vivo studies suggest against potential therapeutic activity of compounds against related coronaviruses, but there are no available data from observational studies or randomized controlled trials in humans to support recommending any investigational therapeutics for patients with confirmed or suspected COVID-19 infection at this time. Remdesivir, an investigational antiviral drug, was reported to have in-vitro activity against COVID-19. A small number of patients with the virus have received intravenous remdesivir for compassionate use outside of a clinical trial setting. A randomized placebo-controlled clinical trial of remdesivir for treatment of hospitalized patients with pneumonia and COVID-19 has begun in China as of press time. A randomized open label trial of combination lopinavirritonavir treatment has also been conducted in hospitalized patients with pneumonia and COVID-19 infection, results were not available as of press time. More clinical trials are being planned. Am I at risk from a package or products shipped from China? COVID-19 is a new virus and there’s a lot we don’t know about it. However, it is genetically related to SARS and MERS, which we do know about. In general, coronaviruses don’t live long on surfaces, so there’s a very low risk from products and packages that were shipped over a period of days or weeks at ambient temperatures. There is no evidence at present to support transmission of COVID-19 through imported goods. What about animals or animal products shipped from China? There is no evidence to suggest that animals or animal products from China will spread COVID-19 in the U.S. The CDC, the U.S. Department of Agriculture and the U.S. Fish and Wildlife Service are monitoring any threats associated with the importation of live animals and animal products into the United States. Are there any travel warnings associated with COVID-19? Yes. The CDC recommends that Americans avoid all nonessential travel to China. In other areas where COVID-19 is sustained, such as Japan and South Korea, the CDC recommends that older adults and those with chronic medical conditions consider postponing nonessential travel. Other areas with a number of COVID-19 cases, such as Hong Kong, Iran and Italy are not warned, the CDC says, but travelers should practice the usual precautions. Destinations with apparent community spread, meaning some people are not sure how or where they became infected, include Singapore, Taiwan, Thailand and Vietnam.
What therapeutic options are available for COVID-19? As of press time, there were no antiviral drugs licensed by the U.S. Food and Drug Administration to treat patients FEBRUARY 2020 |
11
Aclidinium Bromide/Formoterol Fumarate Inhalation Powder In April 2019, the FDA approved a new inhaler: aclidinium bromide/ formoterol fumarate inhalation powder 400mcg/12 mcg. Mechanism of Action Aclidinium bromide is a long-acting, inhaled muscarinic antagonis (LAMA), while formoterol fumarate acts as a By Jessica Bailey long-acting beta-2 agonist (LABA). As aclidinium is an anticholinergic agent, this active ingredient will work on the bronchial smooth muscles in the lungs, resulting in bronchodilation. The following ingredient will selectively block acetylcholine action at muscarinic type-3 receptors through competitive and reversible inhibition. Whereas formoterol is LABA that works to relax bronchial smooth muscles by selectively binding beta-2 receptors. Administered via dry powder inhalation, patients receive 400 mcg of aclidinium and 12 mcg of formoterol per inhalation. For dosing instructions, adults are indicated to take two inhalations twice a day, one inhalation in the morning and the second inhalation in the evening. The maximum daily dose is 800 mcg of aclidinium and 24 mcg of formoterol per day, or two inhalations. Each inhaler delivers 30 to 60 actuations. The inhaler provides a reassuring dual feedback in two ways: via an audible click and colorcontrolled window that changes color upon inhalation.
The dual feedback may help to improve inhalation administrations. Aclidinium bromide/formoterol fumarate is not for the treatment of asthma and is not a rescue medicine or for the treatment of sudden breathing problems. Efficacy and Adverse Effects Aclidinium bromide/formoterol fumarate’s safety and efficacy was evaluated in three dosing ranging trials of 24week duration, and a long-term safety trial of 28 weeks. The dose of aclidinium is supported by a seven-day, randomized, double-blind, active and placebo-controlled, crossover trial 12
|
FLORIDA PHARMACY TODAY
which evaluated doses of 400, 200 and 100 mcg of aclidinium bromide. Within the trial, doses were administered to patients twice daily and once daily in 79 subjects with COPD. The primary outcome was a change from baseline in FEV1 AUC012 from placebo after seven days, in which the 400 mcg dose showed 208 milliliter improvement. The dose of formoterol is supported by a randomized, double-blind, placebo and open-label controlled crossover trial. The three doses of formoterol fumarate evaluated where 24, 12, and 6 mcg doses were evaluated. The following doses were administered daily in 132 subjects with COPD. The primary outcome was a change from baseline in FEV1 AUC0-12 from placebo after seven days, in which the 12 mcg dose showed a 117 milliliter improvement.
ACLIDINIUM BROMIDE IS A LONG-ACTING, INHALED MUSCARINIC ANTAGONIS (LAMA), WHILE FORMOTEROL FUMARATE ACTS AS A LONG-ACTING BETA-2 AGONIST (LABA). Patient Counseling Aclidinium bromide/formoterol fumarate does not need to be primed before first inhalation. Before inhalation, patients should gently squeeze the arrows and pull outwards to remove the cap. Patients should be instructed to hold the mouth piece towards them and with the orange button facing upwards. The inhaler should not be tilted, nor should patients tilt their head downwards upon inhalation. Instead patients should bring the mouthpiece up towards their mouth. The orange button should be pressed all the way down and released, but not held down. The inhaler can be checked if it is ready for inhalation by looking at control window, in which case the color should change from red to green. If so, the green control window confirms the inhaler is ready for inhalation. Patients should make sure to breathe out completely to their side. On the next breath in, patients must place their lips around the mouth piece and take a strong, quick, deep inhalation. A click sound will be heard during inhalations when the inhaler is used correctly. Patients should hold their breathe for a maximum of 10 seconds, or for as long as comfortable, and then breathe out slowly. Patients should be instructed the control window will have turned from green back to red, indicating confirmation of administration of a full dose.
Warnings, Precautions and Contraindications Aclidinium bromide/formoterol fumarate may cause hypersensitivity reactions, upper respiratory tract infection, back pain, bronchospasm as well as central nervous system effects including headache, dizziness and blurred vision. Patients with hypersensitivity to aclidinium, formoterol, or any component of dry powder formulation should avoid use of aclidinium bromide/formoterol fumarate. Dosage form may contain lactose, therefore patients with a severe milk protein allergy should not take aclidinium bromide/ formoterol fumarate because this is a contraindication.It is unknown if aclidinium or formoterol are present in breast milk and patients whom are breastfeeding should speak with their health care provider.
References
1. Center Watch: The Trusted Source for Clinical Trial Information. Duaklir pressair (Aclidinium Bromide and Formoterol Fumarate). https://www.centerwatch.com/druginformation/fda-approved-drugs/drug/100377/duaklirpressair-aclidinium-bromide-and-formoterol-fumarate-. Accessed on 12, February 2020. 2. Circassia Pharmaceuticals Inc.: duaklir pressair. Morrisville, NC. https://www.duaklir.com/. Accessed on 12, February 2020. 3. Lexi-Drugs: duaklir pressair. Wolters Kluwer Health Inc. Riverwoods, IL. http://online.lexi.com.proxy.pba.edu/lco/ action/doc/retrieve/docid/patch_f/5803420?cesid=10XLeuFd Vc7&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dduaklir %2520pressair%2520%26t%3Dname%26va%3Dduaklir%2520p ressair%2520. Accessed on 12, February 2020.
THE DUAL FEEDBACK MAY HELP TO IMPROVE INHALATION ADMINISTRATIONS. ACLIDINIUM BROMIDE/FORMOTEROL FUMARATE IS NOT FOR THE TREATMENT OF ASTHMA AND IS NOT A RESCUE MEDICINE OR FOR THE TREATMENT OF SUDDEN BREATHING PROBLEMS. JANUARY 2020
|
13
“I’M ALWAYS WATCHING OUT FOR MY PATIENTS, BUT WHO’S WATCHING OUT FOR ME?”
WE ARE. We are the Alliance for Patient Medication Safety (APMS), a federally listed Patient Safety Organization. Our Pharmacy Quality Commitment (PQC) program: • • • •
Helps you implement and maintain a continuous quality improvement program Offers federal protection for your patient safety data and your quality improvement work Assists with quality assurance requirements found in network contracts, Medicare Part D, and state regulations Provides tools, training and support to keep your pharmacy running efficiently and your patients safe
Call toll free (866) 365-7472 or visit www.pqc.net PQC IS BROUGHT TO YOU BY YOUR STATE PHARMACY ASSOCIATION 14
|
FLORIDA PHARMACY TODAY
2020 FPA CANDIDATES
FPA Elects Regional Directors and Pharmacist Technician Board Member The Florida Pharmacy Association elected regional directors from regions 2, 4, and 8 and a new pharmacist technician board member for 2020-2022. Tejas Patel, an FPA member since 2018, is an independent pharmacy owner who was educated in India. He was elected as Region 2 representative for Nassau, Duval, Marion, Volusia, Flagler, Putnam, St. Johns and Clay counties. Cheryl Rouse, an FPA member since 2016, owns C&C Community Pharmacy. She was elected as Region 4 representative for Seminole, Orange, Osceola, Lake and Sumter counties. There will be a runoff election for the Region 6 seat between Kathy Pestos and James Wright. Both candidates received equal votes resulting in a tie. Members in those counties — Brevard, Manatee, Hardee, Okeechobee,
Highlands, DeSoto, Sarasota, Charlotte, Glades, Martin, St. Lucie and Indian River counties should watch for information on participating in the runoff election. Carmen Gordon was elected for Region 8, serving Collier, Monroe and Dade counties. Verender Gail Brown, an FPA member since 2006, was elected pharmacist technician board member. She has been a pharmacy technician for more than 40 years. Regions are determined geographically based upon equal numbers of pharmacists residing in that area of the state. Serving until July 2021 are Preston McDonald, Region 1; Larry Alaimo, Region 3; James Alcorn, Region 5; Paul Delisser, Region 7; and Mitchell Levinson, Region 9. Elections for those seats and for treasurer-elect will be this fall.
Onsite State & Federal Regulatory Compliance Consultations Defense of PBM Audits Professional Licensure Disciplinary Proceedings Commercial, Civil Litigation Pharmacy Purchases and Sales
JOIN TODAY!
KAHAN & ASSOCIATES, P.L.L.C. PHARMACIST ATTORNEY BUSINESS BROKER
Brian A. Kahan, R.Ph., J.D.
LICENSED Florida Pharmacist and Attorney STAT EW I DE R EPR E SEN TAT ION 561-392-9000 bkahan@kahanlaw.com 7000 W. Palmetto Park Rd., Suite 210 Boca Raton, FL 33433 The hiring of a lawyer is an important decision that should not be based upon advertisements. Before you decide, ask us to send you free written information about our qualifications and experience.
FEBRUARY 2020
|
15
FPA News & Notes Brevard Pharmacist Runs for APhA Office Theresa Tolle, a Brevard County pharmacist and University of Florida graduate, will run for presidentelect for APhA. She will run against Valerie Prince of Springville, Alabama. Election and complete candidate information will be available online in early March. Voting runs March 20-May 11. Results will be announced in June, and successful candidates will be installed March 12-15, 2021, at the APhA national conference. NPI needed for fee-for-service claims As of March 2, pharmacies must submit fee-for-service claims that contain the National Provider Identifier for a prescriber when an active NPI is known to Florida Medicaid. Active NPI means the prescriber is enrolled with Florida Medicaid; the Florida Department of Health license number will no longer be accepted for prescribers with an active NPI. Pharmacies can expect to receive National Council for Prescription Drug Programs error code 25 — missing/ invalid prescriber ID a the point of sale when a feefor-service claim is submitted that contains the state Department of Health license number for a prescriber with an active NPI. The following supplemental message will post with NCPDP error code 25: Submit prescriber NPI. Your prescriber NPI may be obtained by any of the following methods: ■ Look up the prescriber’s NPI on the National Plan and Provider Enumeration System. ■ Contact the prescirber’s office. ■ Review the agency’s Provider Master List spreadsheet, which is available on the Secure Web Portal. ■ Call the agency’s pharmacy benefit manager, Magellan Medicaid Administration, 877-553-7481. Pharmacies that cannot timely verify prescriber NPI at the point of sale may submit submission clarification code 42 to temporarily override the error. This will allow the claim to process with the prescriber’s Florida DOH license number, but will not override additional errors that may post on the claim for reasons other than prescriber ID. The agency will notify pharmacies when SCC 42 is no longer available to override NCPDP error code 25.
16
|
FLORIDA PHARMACY TODAY
FPA Slates Mental Health Conference The Florida Pharmacy Association will host a mental health clinical conference April 18-19 at the Grand Hyatt, Tampa Bay. The conference will offer the latest information on issues such as ADHD, treatment options for sleep disorders, treatment of memory disorders, and optimizing treatment of anxiety and depression. Consultant recertification and continuing education credits will be available, including the Florida requirements for medication error CE and human trafficking CE. The deadline to register is April 3 and the last day to get group rates at the hotel is March 24 or until the block is full.
FPA Joins Others in Supreme Court Case The Florida Pharmacy Association joined with the National Community Pharmacists Association, the Arkansas Pharmacists Association, the American Pharmacists Association and the National Alliance of State Pharmacy Associations in writing an amicus curiae brief with the Supreme Court of the United States. The associations are supporting a case that pits pharmacy benefit managers against neighborhood health care providers. “The PBMs have been hiding behind a vaguely worded section of a federal law that was never supposed to apply to them,” said B. Douglas Hoey, CEO of NCPA, which represents 21,000 locally owned pharmacies nationwide. “They operate without meaningful regulation, and because of that they’re able to stack the deck in their favor, and at the expense of community pharmacies and their patients.” The case, Rutledge v. the Pharmaceutical Care
Management Association, will be heard April 27. It originates in Arkansas, which passed a law in 2015 that stopped PBMs from reimbursing local pharmacies at a lower rate than what the pharmacies pay to fill the prescriptions. The PBM lobby, the Pharmaceutical Care Management Association, challenged the state law. The case made its way to the federal 8th Circuit Court of Appeals and that judge ruled in favor of the PBMs. Arkansas appealed the ruling, and the Supreme Court agreed to hear the case. “This US Supreme Court will address regulation of an industry built for profits, not patients. The ever-increasing flow of health care funding to the proverbial unregulated middle can be halted, and good patient care can be enhanced when states are permitted to regulate PBMs,” said APhA Executive Vice President and CEO Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA. “Evidence is clear that the profits in the middle come at the expense of everyday Americans and is adversely impacting patient access to pharmacists’ patient care services.” Rebecca Snead, CEO and executive vice president of NASPA, said the federal ERISA law was never meant to shield pharmacy benefit managers from state regulation. “State pha r mac y assoc iat ion s have championed pro-patient, pro-employer, propharmacy legislation for over 25 years with limited success due to the PBMs’ claims that they are pre-empted under ERISA. But the federal ERISA law was never intended to thwart states’ attempts to regulate the business of PBMs or the business of insurance,” Snead said. Thirty-three state attorneys general, both Democrats and Republicans, signed on to an amicus brief in 2018 supporting Arkansas’s appeal of the 8th Circuit Court’s decision to the Supreme Court. “It’s rare to get bipartisan agreement on anyt hing, so t h is level of support i s over whel m i ng ,” Ho ey sa id. “State policymakers have an obligation to protect their residents and their local businesses from predatory business practices. The PBMs are driving up costs for patients, and they are limiting access for patients by systematically shutting down their local pharmacies.”
NEW FPA PRESIDENT ELECT Da n Bu f f i ng ton, a Ta mpa pharmacist, will be t he next president of the Florida Pharmacy Association. Buffington will be installed during the 2020 FPA Convention in July in Marco Island. He is president and practice director of Clinical Pharmacology Services in Tampa and is on the Dan Buffington faculty at the University of Florida College of Medicine and Pharmacy. Buffington provides medication therapy management services; serves as a principal investigator for Phase II and III clinical trials; and manages a national drug information service that provides clinical support for medical practices, health systems and health plans. Buffington’s practice focuses on patients taking chronic or high-risk medications and provides therapy management services to improve health outcomes and patient safety. His practice also includes a forensic pharmacology division that supports medical examiners, law enforcement, state and federal agencies, and provides expert testimony in court cases. “I deeply care about and am very passionate for our profession,” Buffington said. “I have taken a special interest in Legislative Days at the Capitol and have worked as a volunteer facilitator on multiple occasions. Additionally, I have met with legislators and other parties sympathetic to our profession’s issues and have been a staunch advocate for positive change. I have also helped organize grassroots efforts to do the same. I am confident I can be a unifying servant leader that helps propel our association and our profession forward in a positive and sustainable way.” Buffington served for six years on the Board of Trustees of the American Pharmacists Association and represents pharmacists on the American Medical Association’s Current Procedural Terminology Editorial Panel. He served for five years as a medication safety expert with the U.S. Centers for Medicare and Medicaid Services on the Health Care Reform Team in the CMS Innovation Center and the Center for Clinical Standards and Quality. n
FEBRUARY 2020
|
17
2019 Recipients of the “Bowl of Hygeia” Award
Anne Daniels Alabama
Catherine Worhatch Kowalski Alaska
Mark Boesen Arizona
Max Caldwell Arkansas
Thomas Branigan Colorado
Philip Hritcko Connecticut
Madeline Moses Delaware
Carmen Aceves Gordon Florida
Ira Katz Georgia
Mike Minesinger Illinois
Herb Halley Indiana
Marilyn Osterhaus Iowa
Vicki Schmidt Kansas
Catherine Hanna Kentucky
Kim Dupuy Wixson Louisiana
Frank McGrady Maine
Matthew Shimoda Maryland
Adele Pietrantoni Massachusetts
Gary Kadlec Michigan
Karen Bastianelli Minnesota
Randy Calvert Mississippi
Sandra Bollinger Missouri
Todd Koepp Montana
Charles Krobot Nebraska
Diana Quach Nevada
Gary Merchant New Hampshire
John Colaizzi, Jr. New Jersey
Dale McCleskey New Mexico
Bradley Arthur New York
Dennis Williams North Carolina
Dewey Schlittenhard North Dakota
Nnodum Iheme Ohio
John Crumly Oklahoma
Michele Belcher Oregon
Janet Astle Pennsylvania
Lucia Garcia-Carmona Puerto Rico
Anita Jacobson Rhode Island
Wayne Buff South Carolina
Donald Frank South Dakota
Doug Duncan Tennessee
Jennifer Barnett Texas
Roger Fitzpatrick Utah
Kimberly Wright Virginia
Steve Singer Washington
The “Bowl of Hygeia”
In Memoriam: Carl Franklin California
Christopher Keeys Washington DC
Craig Kimble West Virginia
John Muchka Wisconsin
Jennifer Nevins Wyoming
The Bowl of Hygeia award program was originally developed by the A. H. Robins Company to recognize pharmacists across the nation for outstanding service to their communities. Selected through their respective professional pharmacy associations, each of these dedicated individuals has made uniquely personal contributions to a strong, healthy community. We offer our congratulations and thanks for their high example. The American Pharmacists Association Foundation, the National Alliance of State Pharmacy Associations and the state pharmacy associations have assumed responsibility for continuing this prestigious recognition program. All former recipients are encouraged to maintain their linkage to the Bowl of Hygeia by emailing current contact information to awards@naspa.us. The Bowl of Hygeia is on display in the APhA History Hall located in Washington, DC.
18
|
FLORIDA PHARMACY TODAY
CALL FOR ABSTRACTS FOR POSTER PRESENTATIONS FLORIDA PHARMACY ASSOCIATION 130th ANNUAL MEETING AND CONVENTION
July 8-12, 2020 JW Marriott Beach Resort ♦ Marco Island, Florida Poster Session: Friday, July 10, 2020 ♦ 11:00AM-1:00PM COST $ONE COST: ONE DAY DAY REGISTRATION REGISTRATION The FPA Poster Presentations are open to PHARMACISTS, RESIDENTS, STUDENTS, AND TECHNICIANS. Complete and submit this COVERSHEET for each abstract submission. Submissions must be received no later than Friday, May 1, 2020. Abstracts will NOT be accepted after this date. Mail or E-mail this application along with the abstract submission to:
PLEASE TYPE
Tian Merren Owens, MS, PharmD, Director of Continuing Education Florida Pharmacy Association 610 N. Adams Street Tallahassee, FL 32301 tmerren@pharmview.com
Contact Information: Presenter's Name: _______________________________________________________________________________
□ Pharmacist □ Resident
□Student
□ Technician
Address: ________________________________________________________________________________________ City, State, Zip: ___________________________________________________________________________________ Telephone No: _____________________E-Mail Address: _________________________________________________ College of Pharmacy: _____________________________________________________________________________ Abstract Title: ____________________________________________________________________________________ Poster Type:
□Clinical Research □Basic Science Research □Translational Research (Basic Science and Clinical Research)
Primary Author: __________________________________________________________________________________ (Presenter will be notified by mail of acceptance). Co-Author(s): ____________________________________________________________________________________ Awards:
Posters will be eligible for 1st, 2nd, and 3rd place prizes to be presented at Convention. (Only one prize is given for each winning poster)
ABSTRACT FORMAT The abstract form submitted should be the equivalent of one page. The abstract should include: Title (Include authors’ names and name of College of Pharmacy), Purpose, Methods, Results, and Conclusions. Abstracts will not be accepted if it is not in this format. Do not include figures or graphs.
Please direct all questions and concerns to: Tian Merren Owens ♦ (850) 222-2400 ext. 120 ♦ tmerren@pharmview.com DEADLINE DATE: FRIDAY, MAY 1, 2020 FEBRUARY 2020
|
19
CALL FOR RESOLUTIONS TO THE 2020 HOUSE OF DELEGATES The House of Delegates Board of Directors will meet in May 2020 to review and approve resolutions for the Annual Meeting. The deadline for submitting resolutions is May 8, 2020! PLEASE NOTE THIS DEADLINE. The last day to submit items of new business is June 5, 2020. The following information will be needed when submitting resolutions: 1. Name of organization: The name of the organization submitting the resolutions(s); 2. Name and telephone number of individuals: A contact in the event clarification or further information is needed; 3. Problem: A statement of the problem addressed by the resolution; 4. Intent: A statement of what passage of the resolution will accomplish; 5. Resolution Format: Please type and use double spacing. TITLE OF RESOLUTION NAME OF ORGANIZATION WHEREAS , AND
WHEREAS :
THEREFORE BE IT RESOLVED (THAT THE FPA OR SUBDIVISION OF FPA)
CONTACT NAME AND PHONE #: PROBLEM: INTENT:
Return this form to: Membership Coordinator, Florida Pharmacy Association, 610 North Adams Street, Tallahassee, Florida 32301 or fax (850) 561-6758
20
|
FLORIDA PHARMACY TODAY
HELP SUPPORT THE ADOPT-A-STUDENT PROGRAM Florida Pharmacy Association (FPA) 130th Annual Meeting & Convention July 8-12, 2020 JW Marriott Resort – Marco Island, Florida
Again this year, students from Florida Colleges of Pharmacy will be “Adopted” for the FPA Annual Meeting and Convention. Pharmacy students will benefit from the interaction with practicing pharmacists, learn first hand how FPA actually operates and how they can become involved in their chosen profession. As you remember, college students are on a tight budget and most of them cannot afford to attend convention. Here is how you can help! Be a Bronze, Silver or Gold Sponsor! The donation amounts are Bronze ($150), Silver ($250), and Gold ($500) Level Mentor Sponsors and will help offset the costs of the AAS program. You also have the option to give any amount you prefer. The FPA offer Adopted students complimentary registration, which includes admission to the AAS Mentor Social, Exhibit Hall and Student Awards Event. FPA’s programs and services are keys to our success in advocating for our profession, supporting our pharmacy students and promoting quality patient care services. Thank you for giving back to your profession. Make a contribution yourself, ask your local unit association or get together with friends to Adopt-A-Student. Remember…..these are the future leaders of pharmacy! Mentor Program. Each of the adopted students will be assigned a pharmacist who may invite them to attend meetings, CE programs, and share their knowledge and pharmacy experience with them. If you plan to attend the convention and would like to be a mentor, please contact the FPA office. Please donate online at the Foundation’s website, www.flpharmfound.org, or complete the form below and fax or mail with your check to: Florida Pharmacy Foundation PO BOX 266977 Weston, FL 33326 Please make your check payable to the Florida Pharmacy Foundation Sponsor Name: _________________________________________________________________________ Address: ______________________________________________________________________________ City: _______________________________________ State: __________ Zip: _______________________ Phone: ____________________________________ Amount of Contribution: _______________________ Charge to the following:
* AMEX
* DISCOVER
* MASTERCARD
* VISA
Account #:_____________________________________Security Code: ________ Exp. Date: __________ Signature: _____________________________________________________________________________ o Yes, I would like to serve as a Mentor. o Contact me with more information on Mentoring. Contributions to the Florida Pharmacy Foundation are tax deductible as a charitable contribution for federal income tax purposes. Consult your CPA for complete details.
FEBRUARY 2020
|
21
PR
OTE CTING
N” O SI S
E AT N IO
PHARM A C Y PR O FE
LE PEOP
LY D U PRO
“P A S S
130th Annual Meeting and Convention
July 8 – 12, 2020 JW Marriott Resort Marco Island, FL
22
|
FLORIDA PHARMACY TODAY
Keynote Speaker Christopher Jerry lost his beautiful two-year-old daughter, Emily, after a fatal medication error in March of 2006. After the tragic loss, he created the Emily Jerry Foundation to increase awareness of key patient safety related issues associated with preventable medical error, which by recent estimates, have been identified as being the third leading cause of death in the United States. Over the past decade, Mr. Jerry has had the privilege of collaborating with many of the experts in the various modalities in medicine, to focus on the modification of underlying core systems, processes, and protocols, to help keep patients safe and assure the best possible outcome for each and every patient. In doing so, he has worked tirelessly with some of the brightest minds in healthcare, to identify technology and best practices, that are proven to minimize the inherent “human error component” associated with patient care in the clinical setting. Through what Mr. Jerry considers his life’s work, his primary objective going forward, will always be to help stop tragedies BEFORE they happen…ultimately saving as many lives as possible from preventable medical error. He is a relentless patient safety and clinician advocate who spreads a message of hope, forgiveness, compassion, and collaboration, by turning an unimaginable tragedy, into inspiring positive change, globally in healthcare, in honor of his daughter Emily.
Accommodations
ROOM RATES: $229 plus tax based on single/double occupancy. The room reservation deadline is Friday, June 19, 2020 or when room block is full. Thereafter, reservations may be taken on a space available or rate available basis. There is an optional resort fee. Self-parking is discounted $10 per day. Please be sure to ask for the Florida Pharmacy Association group rate. All reservations must be accompanied by a first night room deposit or guaranteed with a major credit card. The check-in time is 4:00pm and the checkout time is 11:00 am. Room reservations can be made by calling (800) 438-4373 or (239) 394-2511.
LE PEOP E AT N O I “P A S S
The general education track will offer courses designed to educate pharmacists on a wide variety of important topics pertaining to the profession of pharmacy practice. Specific required Florida Board Approved courses being offered are Reducing Medication Errors, HIV/AIDS, Human Trafficking, Validation of Controlled Substances and the Ordering and Evaluating Laboratory Tests. There will also be courses on Pharmacy Burnout and Resiliency, Vaccines & Myth Busters, and Legislative Update!
OTE CTING
N” O SI S
THURSDAY - SUNDAY
PR
PHARMA CY P RO FE
General Education Track
Y DL PROU
FEBRUARY 2020
|
23
Consultant Education Track FRIDAY - SATURDAY
The consultant education track will provide pharmacists with the most current information available on various topics that pharmacists encounter in the profession of pharmacy. The consultant track will focus on Nutrition, Autoimmune Disorders and and Specialty Pharmacy. The specific topics being offered include Vitamins and Herbals, Arthritis, Multiple Sclerosis, Pain Management, Marijuana and Hemp, Oncology and Pharmacogenomics. There are 12 hours available for consultant pharmacists.
Student and Technician Track THURSDAY - SUNDAY
Students and Technicians will benefit from interacting with practicing pharmacists and attending student and technician focused continuing education programs. The technician track offers several hours of continuing education on Medication Safety, Roles for Technicians, and the required courses for Florida registration and PTCB renewal: Medication Errors, HIV/AIDS, and Law. The student track consists of several hours of fun and exciting continuing education, such as The Career Forum, the NASPA/NMA Game Show and a Leadership Course. Students will also have an opportunity to participate in the Patient Counseling Competition and showcase their Poster Presentations.
Special Events FPPC RECEPTION: Attend this reception to support your Political Action Committee. HOUSE OF DELEGATES: Be a delegate or observer and see how important member participation is to the direction of the Association. PRESIDENT’S 250 CLUB: Contribute to the president’s club and be invited to a private reception. EXHIBITS: Participate in the grand opening reception in the exhibit hall! Visit with exhibitors, introduce yourself, shake their hands, tell them you appreciate them and invite them back next year! The exhibitors are a very important part of FPA’s convention. Companies send their representatives to educate you about their products and services at great expense. Please show them your appreciation! POSTER PRESENTATIONS: Browse submissions from all pharmacy professionals. Contact the FPA office for more information if you would like to submit a poster presentation. RECEPTIONS: Enjoy catching up with your colleagues as the Universities entertain their alumni and friends followed by a night of Karaoke Fun! STUDENT EVENTS: Participate in the Adopt-A-Student Mentor Social. Students will benefit from interacting with practicing pharmacists, attending student focused continuing education programs and learning firsthand about the FPA and how involvement can improve their chosen profession. Call the FPA office and offer to mentor or sponsor a student. FUN RUN WALK: Exercise is good for the soul. Incorporate health and fitness while at the FPA convention. Please register early to reserve your space. AWARDS EVENT: Honor outstanding practitioners during the awards presentation. INSTALLATION OF OFFICERS: Attend the installation of NEW officers on Sunday morning!
For More Information Call (850) 222-2400. 24
|
FLORIDA PHARMACY TODAY
1
FPA 130th Annual Meeting and Convention July 8-12, 2020 Marco Island, FL
,
55Daily Education Registration
Participant Information Participant Information
Daily registration does not include admittance to functions or handbooks. Handouts will be posted on our website July 6.
Name: _____________________________________________________ Name _______________________________________________ Address______________________________________________ Badge Name: _______________________________________________ City, State, Zip_________________________________________ Mailing Address: ____________________________________________ Phone___ ________________________ City, State, Zip: _____________________________________________ Email________________________________________________ Phone: (W) (H)_______________________ Practice Setting________________________________________ License: PS______________ PU _____________RPT_________ Fax: ______________________________________________________ NABP Date of Birth___________ License:e-profile#__________________ PS________________ PU_________ Other State________ Emergency Contact Name/Number_________________________
2
Before
June 19
Full Package Registration
2FPA Member
Before June 19
Onsite
Amount_
$430
$_______
$345
Amount
FPA Member
$165
$185
$_______
Non Member
$215
$235
$_______
Member Technician
$65
$85
$_______
Non Member Technician
$90
$110
$_______
Handbooks
$40
$40
$_______
Please select the day(s) you will attend: Thursday
Full package registration includes Educational Programs Thursday-Sunday, House of Delegates on Thursday, Exhibit Hall Friday and Saturday, Receptions, and Awards Event on Saturday. Handbooks are not included in full package registration. Handouts will be available the week of the convention on our website, www.floridapharmacy.org.
Onsite
6
Friday
Saturday
Sunday
Additional Tickets
The following events are included in the Full Registration Package, if requested. However, you must purchase additional tickets for guests who are NOT registered. Quantity
Price
Amount
Exhibit Hall
$30
$______
Awards Event
$80
$______
7
Non Member
$525
$610
$_______
Pharmacist BEST Value
$540
$625
$_______
Member Technician
$155
$185
$_______
Non Member Technician
$175
$210
$_______
Technician BEST Value
$185
$220
$_______
$150
$170
$_______
Poster Presenter
$40
$40
$_______
(Registration fee is based upon membership and professional status for Non-convention registrants.)
3Student
Handbooks
(BEST Value includes Registration & Membership)
3
House of Delegates (Thursday)
FPPC Reception (Thursday)
Exhibit Hall (Friday and/or Saturday)
Awards Event (Saturday)
Christian Fellowship (Sunday)
I will not attend any of these functions.
4
House of Delegates
House of Delegates (Non-convention registrants)
Quantity
8
_______
Amount $______
$50
$______
FPA Polo Shirt (Deadline is June 5) Quantity Price
9
Price
One Day Registration
Student Awards Event
Please indicate below which functions you will attend. If no boxes are selected, we will assume you will not attend any of the events listed below. Please see box 6 for additional tickets.
Special Events Registration
The Poster Event is available to all pharmacy professionals and included in full and daily registrations. The Student Awards Event is not included in any registration packages.
Yes
______
Payment
$35
M/F ______
Size ______
Amount $_______
Total Enclosed: $______
Check (To: FPA) AMEX Discover MasterCard Visa Account # ____________________________________________ Security Code _________________ Expiration Date __________
Before June 11
Amount
$165
______
Billing Address ________________________________________ Signature ____________________________________________
Four Ways to Register
Mail: FPA, 610 North Adams Street, Tallahassee, FL 32301 Phone: 850-222-2400 Fax: 850-561-6758 Web: www.floridapharmacy.org
Schedule and Fee Subject to Change
FEBRUARY 2020
|
25
Quick, Easy, and Secure REGISTER FOR OUR ONLINE SERVICES TODAY!
MEMBER PORTAL
RISK MANAGEMENT CENTER
PAPERLESS BILLING
! *Only Available for Commercial Accounts
*Not available in the state of Ohio
TO ACCESS YOUR ACCOUNT ONLINE VISIT: https://www.phmic.com/memberportal You will need your customer number and email address.
Pharmacists Mutual Insurance Company 808 Highway 18 W | PO Box 370 | Algona, Iowa 50511 P. 800.247.5930, ext. 4050 | F. 515.295.9306 | E. member.services@phmic.com
phmic.com
